Thursday, May 13, 2021

InspireMD, Inc. (NSPR) Stock Trends Upwards After a Troubling 2020

Up 0.38% as of market close on April 14th, 2021, InspireMD, Inc. (NSPR) sat at USD$0.5538. This came hot on the heels of news of a 1-for-15 reverse split of NSPR’s common stock. This change will come into effect on April 26th, 2021, and will result in a reduced number of outstanding shares of its common stock.


5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored



InspireMD Public Offering

Early February of 2021 saw the closing of its public offering of USD$20.7 million. Initially, the offering was for gross proceeds of USD$18 million, with an option for underwriters to exercise that would net NSPR USD$20.7 million. The offering was comprised of 2,9032,258 units, listed for a price of USD$0.62 per unit. NSPR stock prices saw a significant surge following this news.

Enlisting Experts


A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .

Sponsored


Further developments that have the potential to bolster NSPR’s outlook include the inclusion of highly renowned interventional cardiologist Gary Roubin M.D., Ph.D., to the Board of Directors. Chris Metzger, M.D., was also appointed as the primary investigator for the upcoming FDA registration trial for NSPR’s flagship product CGuard EPS. Furthermore, CGuard Carotid Stent System clinical trials in the US were announced to be conducted by a leading Contract Research Organisation (CRO), Hart Clinical Consultants (HCC).

Bleak 2020 Financials

Revenues in the three-month period ending December 31st, 2020 saw a devastating 84.4% drop in revenue from the same period of the previous year. Besides the effects of the pandemic curtailing financial growth, NSPR also had to settle litigation with a former distributor in regard to a 2014 transaction. This negatively impacted 2020 financials for the company, with the one-time occurrence seeing NSPR charging USD$580,000 against their sales as per US GAAP.

What’s Next for NSPR?

Despite a rocky 2020, NSPR is highly confident for the future. They are in a stable financial position following their IPOs over the last year and have enlisted various expert entities to help facilitate the FDA approval of CGuard EPS. How these translate into the sustained increased value of NSPR stock is yet to be seen.

Latest news

What is behind the fall of Torchlight Energy Resources Inc. (NASDAQ: TRCH) stock?

Torchlight Energy Resources, Inc. (NASDAQ: TRCH), a growth oil and gas exploration company specializing in the acquisition and development of highly profitable domestic oil...

Eros STX Global Corporation (ESGC) stock is declining: Here is the reason why?

Eros STX Global Corporation (NYSE ESGC) a global multinational media company that acquires, produces, and distributes films, television shows, and digital content issued its...

Yum China Holdings Inc. (YUMC): The Most Important Numbers You Should Know

Yum China Holdings Inc. (YUMC), which operates Taco Bell Restaurants, KFC Restaurants, and Pizza Hut Restaurants in China, has published its first-quarter report for...

Why shares of Akerna Corp. (KERN) stock are up today?

Akerna (KERN), a cannabis technology company focusing to connect data points in the global cannabis supply chain and developer of the cannabis industry's first...

Related news

What is behind the fall of Torchlight Energy Resources Inc. (NASDAQ: TRCH) stock?

Torchlight Energy Resources, Inc. (NASDAQ: TRCH), a growth oil and gas exploration company specializing in the acquisition and development of highly profitable domestic oil...

Eros STX Global Corporation (ESGC) stock is declining: Here is the reason why?

Eros STX Global Corporation (NYSE ESGC) a global multinational media company that acquires, produces, and distributes films, television shows, and digital content issued its...

Yum China Holdings Inc. (YUMC): The Most Important Numbers You Should Know

Yum China Holdings Inc. (YUMC), which operates Taco Bell Restaurants, KFC Restaurants, and Pizza Hut Restaurants in China, has published its first-quarter report for...

Why shares of Akerna Corp. (KERN) stock are up today?

Akerna (KERN), a cannabis technology company focusing to connect data points in the global cannabis supply chain and developer of the cannabis industry's first...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.